文献速递神经肿瘤

脑膜瘤的诊断挑战

Diagnostic challenges in meningioma.
PubMed 文献 · Neuro Oncol · 2017-01-01

本综述从神经影像和神经病理两方面阐述脑膜瘤诊断面临的挑战,介绍先进MRI和PET在肿瘤精确描绘、生长评估及病理生理参数方面的应用,以及高通量测序和DNA甲基化分析对预测生物学行为和临床病程的潜在价值,并指出全分子检测成本高、耗时长可能延迟临床常规实施。

要点

  • 先进MRI和PET有助于脑膜瘤的精确描绘、生长评估和病理生理参数评价。
  • 高通量测序和DNA甲基化分析可更可靠预测脑膜瘤生物学行为和临床病程。
  • 全分子检测较组织学评估成本更高、耗时更长,可能延迟其临床常规实施。

核心结论

  • 先进影像技术和分子检测有望帮助克服脑膜瘤诊断挑战,但全分子检测成本高、耗时长可能延迟临床常规实施。

研究设计与样本

  • 综述,整合非标准影像和分子评估数据,补充近期提出的欧洲神经肿瘤协会脑膜瘤治疗与诊断指南。

主要发现

  • 先进MRI和PET近期被用于脑膜瘤的精确肿瘤描绘、肿瘤生长评估和病理生理参数评价。
  • 高通量测序和DNA甲基化分析极大增进了对脑膜瘤分子异常的认识。
  • 这些技术可更可靠预测脑膜瘤的生物学行为和临床病程,并具有指导个体化治疗的潜力。
  • 与组织学评估相比,全分子检测成本更高、耗时更长,可能延迟其融入临床常规。

局限性

  • 全分子检测与组织学评估相比成本更高、耗时更长,可能延迟其融入临床常规。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Advances in molecular profiling and the application of advanced imaging techniques are currently refreshing diagnostic considerations in meningioma patients. Not only technical refinements but also sophisticated histopathological and molecular studies have the potential to overcome some of the challenges during meningioma management. Exact tumor delineation, assessment of tumor growth, and pathophysiological parameters were recently addressed by "advanced" MRI and PET. In the field of neuropathology, high-throughput sequencing and DNA methylation analysis of meningioma tissue has greatly advanced the knowledge of molecular aberrations in meningioma patients. These techniques allow for more reliable prediction of the biological behavior and clinical course of meningiomas and subsequently have the potential to guide individualized meningioma therapy. However, higher costs and longer duration of full molecular work-up compared with histological assessment may delay the implementation into clinical routine.This review highlights the diagnostic challenges of meningiomas from both the neuroimaging as well as the neuropathological side and presents the latest scientific achievements and studies potentially helping in overcoming these challenges. It complements the recently proposed European Association of Neuro-Oncology guidelines on treatment and diagnosis of meningiomas by integrating data on nonstandard imaging and molecular assessments most likely impacting the future.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Nowosielski M, Galldiks N, Iglseder S, et al. Diagnostic challenges in meningioma. Neuro Oncol. 2017. PMID: 28531331. doi:10.1093/neuonc/nox101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。